1589 related articles for article (PubMed ID: 21948594)
1. ChEMBL: a large-scale bioactivity database for drug discovery.
Gaulton A; Bellis LJ; Bento AP; Chambers J; Davies M; Hersey A; Light Y; McGlinchey S; Michalovich D; Al-Lazikani B; Overington JP
Nucleic Acids Res; 2012 Jan; 40(Database issue):D1100-7. PubMed ID: 21948594
[TBL] [Abstract][Full Text] [Related]
2. The ChEMBL bioactivity database: an update.
Bento AP; Gaulton A; Hersey A; Bellis LJ; Chambers J; Davies M; Krüger FA; Light Y; Mak L; McGlinchey S; Nowotka M; Papadatos G; Santos R; Overington JP
Nucleic Acids Res; 2014 Jan; 42(Database issue):D1083-90. PubMed ID: 24214965
[TBL] [Abstract][Full Text] [Related]
3. Collation and data-mining of literature bioactivity data for drug discovery.
Bellis LJ; Akhtar R; Al-Lazikani B; Atkinson F; Bento AP; Chambers J; Davies M; Gaulton A; Hersey A; Ikeda K; Krüger FA; Light Y; McGlinchey S; Santos R; Stauch B; Overington JP
Biochem Soc Trans; 2011 Oct; 39(5):1365-70. PubMed ID: 21936816
[TBL] [Abstract][Full Text] [Related]
4. ChEMBL web services: streamlining access to drug discovery data and utilities.
Davies M; Nowotka M; Papadatos G; Dedman N; Gaulton A; Atkinson F; Bellis L; Overington JP
Nucleic Acids Res; 2015 Jul; 43(W1):W612-20. PubMed ID: 25883136
[TBL] [Abstract][Full Text] [Related]
5. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
Zdrazil B; Felix E; Hunter F; Manners EJ; Blackshaw J; Corbett S; de Veij M; Ioannidis H; Lopez DM; Mosquera JF; Magarinos MP; Bosc N; Arcila R; Kizilören T; Gaulton A; Bento AP; Adasme MF; Monecke P; Landrum GA; Leach AR
Nucleic Acids Res; 2024 Jan; 52(D1):D1180-D1192. PubMed ID: 37933841
[TBL] [Abstract][Full Text] [Related]
6. The ChEMBL database in 2017.
Gaulton A; Hersey A; Nowotka M; Bento AP; Chambers J; Mendez D; Mutowo P; Atkinson F; Bellis LJ; Cibrián-Uhalte E; Davies M; Dedman N; Karlsson A; Magariños MP; Overington JP; Papadatos G; Smit I; Leach AR
Nucleic Acids Res; 2017 Jan; 45(D1):D945-D954. PubMed ID: 27899562
[TBL] [Abstract][Full Text] [Related]
7. ChEMBL: towards direct deposition of bioassay data.
Mendez D; Gaulton A; Bento AP; Chambers J; De Veij M; Félix E; Magariños MP; Mosquera JF; Mutowo P; Nowotka M; Gordillo-Marañón M; Hunter F; Junco L; Mugumbate G; Rodriguez-Lopez M; Atkinson F; Bosc N; Radoux CJ; Segura-Cabrera A; Hersey A; Leach AR
Nucleic Acids Res; 2019 Jan; 47(D1):D930-D940. PubMed ID: 30398643
[TBL] [Abstract][Full Text] [Related]
8. A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
Mutowo P; Bento AP; Dedman N; Gaulton A; Hersey A; Lomax J; Overington JP
J Biomed Semantics; 2016 Sep; 7(1):59. PubMed ID: 27678076
[TBL] [Abstract][Full Text] [Related]
9. Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
Nowotka MM; Gaulton A; Mendez D; Bento AP; Hersey A; Leach A
Expert Opin Drug Discov; 2017 Aug; 12(8):757-767. PubMed ID: 28602100
[TBL] [Abstract][Full Text] [Related]
10. PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach.
Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
SAR QSAR Environ Res; 2015; 26(10):783-93. PubMed ID: 26305108
[TBL] [Abstract][Full Text] [Related]
11. Illuminating the druggable genome through patent bioactivity data.
Magariños MP; Gaulton A; Félix E; Kiziloren T; Arcila R; Oprea TI; Leach AR
PeerJ; 2023; 11():e15153. PubMed ID: 37151295
[TBL] [Abstract][Full Text] [Related]
12. AtlasCBS: a web server to map and explore chemico-biological space.
Cortés-Cabrera A; Morreale A; Gago F; Abad-Zapatero C
J Comput Aided Mol Des; 2012 Sep; 26(9):995-1003. PubMed ID: 22798082
[TBL] [Abstract][Full Text] [Related]
13. PPDMs-a resource for mapping small molecule bioactivities from ChEMBL to Pfam-A protein domains.
Kruger FA; Gaulton A; Nowotka M; Overington JP
Bioinformatics; 2015 Mar; 31(5):776-8. PubMed ID: 25348214
[TBL] [Abstract][Full Text] [Related]
14. myChEMBL: a virtual machine implementation of open data and cheminformatics tools.
Ochoa R; Davies M; Papadatos G; Atkinson F; Overington JP
Bioinformatics; 2014 Jan; 30(2):298-300. PubMed ID: 24262214
[TBL] [Abstract][Full Text] [Related]
15. CREDO: a structural interactomics database for drug discovery.
Schreyer AM; Blundell TL
Database (Oxford); 2013; 2013():bat049. PubMed ID: 23868908
[TBL] [Abstract][Full Text] [Related]
16. CMNPD: a comprehensive marine natural products database towards facilitating drug discovery from the ocean.
Lyu C; Chen T; Qiang B; Liu N; Wang H; Zhang L; Liu Z
Nucleic Acids Res; 2021 Jan; 49(D1):D509-D515. PubMed ID: 32986829
[TBL] [Abstract][Full Text] [Related]
17. SureChEMBL: a large-scale, chemically annotated patent document database.
Papadatos G; Davies M; Dedman N; Chambers J; Gaulton A; Siddle J; Koks R; Irvine SA; Pettersson J; Goncharoff N; Hersey A; Overington JP
Nucleic Acids Res; 2016 Jan; 44(D1):D1220-8. PubMed ID: 26582922
[TBL] [Abstract][Full Text] [Related]
18. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data.
Muresan S; Petrov P; Southan C; Kjellberg MJ; Kogej T; Tyrchan C; Varkonyi P; Xie PH
Drug Discov Today; 2011 Dec; 16(23-24):1019-30. PubMed ID: 22024215
[TBL] [Abstract][Full Text] [Related]
19. IntAct: an open source molecular interaction database.
Hermjakob H; Montecchi-Palazzi L; Lewington C; Mudali S; Kerrien S; Orchard S; Vingron M; Roechert B; Roepstorff P; Valencia A; Margalit H; Armstrong J; Bairoch A; Cesareni G; Sherman D; Apweiler R
Nucleic Acids Res; 2004 Jan; 32(Database issue):D452-5. PubMed ID: 14681455
[TBL] [Abstract][Full Text] [Related]
20. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.
Lagarde N; Ben Nasr N; Jérémie A; Guillemain H; Laville V; Labib T; Zagury JF; Montes M
J Med Chem; 2014 Apr; 57(7):3117-25. PubMed ID: 24666037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
